State of Illinois
92nd General Assembly
Legislation

   [ Search ]   [ PDF text ]   [ Legislation ]   
[ Home ]   [ Back ]   [ Bottom ]



92_HB0331

 
                                               LRB9204203DJgc

 1        AN ACT in relation to aging.

 2        Be it enacted by the People of  the  State  of  Illinois,
 3    represented in the General Assembly:

 4        Section  5.  The  Senior  Citizens  and  Disabled Persons
 5    Property Tax Relief  and  Pharmaceutical  Assistance  Act  is
 6    amended by changing Section 3.15 as follows:

 7        (320 ILCS 25/3.15) (from Ch. 67 1/2, par. 403.15)
 8        Sec.  3.15.   "Covered  prescription  drug" means (1) any
 9    cardiovascular agent  or  drug;  (2)  any  insulin  or  other
10    prescription   drug   used  in  the  treatment  of  diabetes,
11    including syringe and needles used to administer the insulin;
12    (3) any prescription drug used in the treatment of arthritis,
13    (4) beginning on January 1, 2001, any prescription drug  used
14    in the treatment of cancer, (5) beginning on January 1, 2001,
15    any  prescription  drug  used in the treatment of Alzheimer's
16    disease, (6) beginning on January 1, 2001,  any  prescription
17    drug  used  in  the  treatment  of  Parkinson's  disease, (7)
18    beginning on January 1, 2001, any prescription drug  used  in
19    the  treatment  of  glaucoma, and (8) beginning on January 1,
20    2001, any prescription drug used in  the  treatment  of  lung
21    disease  and  smoking related illnesses, and (9) beginning on
22    January 1, 2002, any prescription drug used in the  treatment
23    of  multiple sclerosis. The specific agents or products to be
24    included under such categories shall be listed in a  handbook
25    to  be  prepared   and  distributed  by  the Department.  The
26    general  types  of  covered  prescription  drugs   shall   be
27    indicated  by  rule.  The  Department  of Public Health shall
28    promulgate a list of covered prescription  drugs  under  this
29    program  that  meet  the  definition  of a narrow therapeutic
30    index drug as described in subsection (f) of Section 4.
31    (Source: P.A. 91-699, eff. 1-1-01.)

[ Top ]